Thibault Mazard

Institut de Cancérologie de ­Montpellier

3
Articles

About

Montpellier Cancer Institute (ICM), Department of Medical Oncology, University of Montpellier, Montpellier Cancer Research Institute (IRCM), INSERM U1194, Montpellier

Latest publication

Journal article

News in the management of patients with unresectable metastatic colorectal cancers with BRAFV600E mutation

In Hépato-Gastro & Oncologie Digestive (2026/3 Vol. 33)


Most viewed articles

Journal article

Biomarkers for digestive cancers in 2025: Revisiting the basics and learning new lessons

In Hépato-Gastro & Oncologie Digestive (2025/7 Vol. 32)


Co-authors

  • Bénédicte Demoustier

    Institut de Cancérologie de Montpellier

    1
    Article
  • Nadim Fares

    CHU de Toulouse

    5
    Articles
  • Claire Gallois

    7
    Articles
  • Cindy Neuzillet

    Institut Curie

    20
    Articles
  • Rosine Guimbaud

    CHU de Toulouse

    6
    Articles
  • Frédéric Bibeau

    CHU Jean Minjoz

    2
    Articles
  • Erwan Vo-Quang

    2
    Articles
  • Arnaud Uguen

    1
    Article
  • Coralie Prévost

    3
    Articles
  • Anne-Cécile Brunac

    1
    Article
  • Simon Garinet

    1
    Article
  • Hélène Blons

    1
    Article
  • Janick Selves

    2
    Articles
  • Frédéric Di Fiore

    CHU de Rouen

    7
    Articles

Articles

This action will reload the page results.
Journal article

News in the management of patients with unresectable metastatic colorectal cancers with BRAFV600E mutation

In Hépato-Gastro & Oncologie Digestive (2026/3 Vol. 33)

Journal article

Biomarkers for digestive cancers in 2025: Revisiting the basics and learning new lessons

In Hépato-Gastro & Oncologie Digestive (2025/7 Vol. 32)

Journal article

Triplet chemotherapy in metastatic colorectal cancer: Which patients, when, how, and with what targeted therapies?

In Hépato-Gastro & Oncologie Digestive (2024/4 Vol. 31)